AlphaSimPlex Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,252
Closed -$222K 74
2022
Q1
$222K Sell
1,252
-421
-25% -$71.6K 0.81% 58
2021
Q4
$286K Sell
1,673
-1,988
-54% -$325K 0.49% 66
2021
Q3
$591K Sell
3,661
-3,799
-51% -$648K 0.49% 66
2021
Q2
$1.23M Hold
7,460
0.61% 43
2021
Q1
$1.23M Buy
7,460
+2,437
+49% +$394K 0.51% 56
2020
Q4
$791K Sell
5,023
-1,403
-22% -$207K 0.28% 161
2020
Q3
$957K Buy
6,426
+2,737
+74% +$405K 0.44% 73
2020
Q2
$519K Buy
+3,689
New +$538K 0.39% 136
2020
Q1
Sell
-8,707
Closed -$1.27M 178
2019
Q4
$1.27M Hold
8,707
0.48% 39
2019
Q3
$1.13M Sell
8,707
-1,617
-16% -$213K 0.43% 91
2019
Q2
$1.44M Sell
10,324
-1,966
-16% -$272K 0.45% 72
2019
Q1
$1.72M Buy
+12,290
New +$1.65M 0.58% 36

Other funds holding JNJ

AlphaSimPlex Group's JNJ Position: Q2 2022 in Review

AlphaSimPlex Group sold out of Johnson & Johnson (JNJ) in Q2 2022, closing a stake of 1,252 shares — an estimated $222K sold.

AlphaSimPlex Group first reported a position in JNJ in Q1 2019 and held it in 12 quarters. The position peaked at $1.72M in Q1 2019. 3,671 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

  • AlphaSimPlex Group reported no remaining Johnson & Johnson position as of Q2 2022 after selling out during the quarter.
  • AlphaSimPlex Group sold 1,252 Johnson & Johnson shares in Q2 2022, an estimated $222K.
  • AlphaSimPlex Group first reported a position in Johnson & Johnson in Q1 2019 and held it in 12 quarters.
  • AlphaSimPlex Group's Johnson & Johnson position peaked at $1.72M in Q1 2019.
  • 3,671 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on AlphaSimPlex Group's 13F filing for Q2 2022, filed 10 Aug 2022.